Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about lead, mercury, arsenic, and other toxic elements in Ayurvedic products.

A careful reading is more useful than either blanket fear or blanket reassurance. Properly manufactured bhasma is not the same as accidental heavy-metal contamination in an herbal capsule, because its intended material, processing, particle size, and chemical form all matter. At the same time, laboratory testing has repeatedly found unsafe metals in some commercial Ayurvedic products, especially products bought from unverified sources. Safety depends on identity, classical processing, chemical speciation, batch testing, dose, duration, and medical supervision.

What Are Bhasma Preparations?

Bhasma means an ash-like calcined product. In Rasa Shastra pharmaceutics, a metal, mineral, shell, pearl, coral, or related material is processed through purification and incineration stages known broadly as shodhana and marana. The material may be triturated with herbal juices or decoctions, made into pellets, sealed in earthen containers, and repeatedly heated. The intended result is a fine, lusterless, stable preparation rather than crude metal powder.

Classical and pharmaceutic quality checks are used to judge whether incineration has reached the expected endpoint. Modern laboratories add elemental analysis and structural analysis to these traditional tests, because the same named bhasma can vary by raw material, heating method, number of calcination cycles, and manufacturer.

What Modern Analysis Adds

Modern testing separates several questions that are often mixed together: how much of an element is present, what chemical compound it is present as, what particle size and morphology it has, whether toxic impurities are present, and how much enters systemic circulation. ICP-MS, ICP-OES, ICP-AES, X-ray fluorescence, X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and related methods each answer different parts of that safety question.

Total metal content alone is not enough to judge a genuine metal-based bhasma, because a gold, iron, copper, zinc, tin, lead, or mercury preparation will naturally contain the intended element. For safety, total elemental analysis must be read together with chemical form, solubility, particle size, dose, duration, patient factors, and batch purity. For herbal-only products, however, lead, mercury, arsenic, and cadmium are contaminants unless clearly declared and justified by the formulation.

Swarna Bhasma: Gold Content, Particle Form, and Absorption

Swarna Bhasma is one of the most discussed bhasma preparations because gold is a noble metal and the prescribed doses are small. Published characterization work has reported gold as the major phase in prepared samples, but the percentage and particle dimensions vary across preparations and methods.

In one pharmaceutical standardization study, Swarna Bhasma prepared through a traditional method passed selected bhasma tests such as varitaratva, rekhapurnatva, and expected color. The finished product contained 52.33% gold by ICP-OES, with lead and cadmium below detection limits in that batch, while arsenic and mercury were detected. The same report also recorded particle sizes in the 1–10 µm range by spot magnification, showing that not every finished product can be described simply as a uniform nanoparticle preparation.

A human pilot bioavailability assessment administered Swarnabhasma in three regimens and measured blood gold using ICP-MS. Gold was detected only in trace amounts after a single dose. This supports cautious dosing and supervision rather than casual long-term self-use, because trace absorption does not remove the need for product identity and contaminant testing.

Tamra Bhasma: Copper Form Is Central to Safety

Tamra Bhasma requires special caution because copper in inappropriate form or excessive dose can cause gastrointestinal and systemic toxicity. The Ayurvedic safety logic is that copper must be purified, repeatedly processed, and converted into a stable bhasma that passes classical endpoint tests.

A quality-control study of Tamra Bhasma prepared from copper wire applied shodhana, marana, and amritikarana, then evaluated the final product using classical tests and modern tools. The final product passed tests such as rekhapurnatva and varitaratva. XRD showed prominent peaks of cupric sulfide, SEM showed particles below 2 µm, particle-size distribution gave a volumetric mean diameter of 28.70 µm, and ICP-AES measured 56.42% copper with 23.06% sulfur. Arsenic, lead, and mercury were present only in traces in that sample, while cadmium and selenium were not detected.

These details are important because they correct an oversimplified claim often made in discussions of Tamra Bhasma: a named bhasma cannot be assumed to be only one oxide form, nor can safety be inferred from name alone. The batch must be tested.

Lauha Bhasma and Yashada Bhasma: Iron and Zinc Preparations

Lauha Bhasma and Yashada Bhasma are often discussed as lower-concern metal bhasma when properly manufactured, because iron and zinc are essential elements. That does not mean they are risk-free. Excess iron can accumulate in susceptible patients, and zinc preparations can vary in chemical form and impurities.

Work on Lauha Bhasma preparation has described the importance of sequential purification and calcination in changing raw iron into a more processed iron-based material. Structural investigation of medicinal-grade Lauha Bhasma reported conversion of metallic iron into iron-oxide mineral phases, with magnetite microparticles appearing as agglomerates of nanoparticles. Yashada Bhasma analyses have reported zinc oxide or zinc sulfide phases depending on the processing method, with ICP-based elemental profiling used to assess trace elements and heavy metals.

The JAMA Internet-Product Survey: What It Really Means

The widely cited JAMA survey of Ayurvedic medicines sold via the internet remains highly relevant for public safety. It purchased 230 products, received and analyzed 193, and found detectable lead, mercury, or arsenic in 20.7% of products. Rasa Shastra products had a higher prevalence of detectable metals than non-Rasa Shastra products, and all metal-containing products exceeded at least one standard for acceptable daily intake of toxic metals.

The survey should be read as a serious product-quality warning. It tested commercial products bought online, not carefully supervised individualized prescribing from a qualified practitioner. It also measured metal concentrations rather than clinical pharmacokinetics or chemical speciation. Still, its practical message is unavoidable: consumers cannot assume an Ayurvedic label, an online listing, or a stated GMP claim guarantees safety.

Total Metal, Chemical Form, and Bioavailability

Total metal content answers only one part of the safety question. Iron oxide, elemental iron, soluble iron salts, and iron bound in hemoglobin all contain iron but behave differently in the body. The same principle applies to copper, zinc, mercury, lead, and arsenic: chemical form and solubility matter.

Mercury illustrates the point clearly. Cinnabar and mercuric sulfide are poorly absorbed from the gastrointestinal tract compared with methylmercury and more soluble mercury salts. This distinction is chemically meaningful, but it is not a license for self-medication with mercury-containing preparations. Poor absorption does not mean zero absorption, and cumulative exposure, impurities, overheating, wrong processing, wrong dose, and vulnerable patients can still create risk.

Which Bhasma Carry Lower or Higher Concern?

A practical safety ranking should not claim that any bhasma is automatically safe. It should separate lower-concern mineral preparations from preparations that contain toxic metals or require especially narrow dosing discipline.

Lower Concern When Properly Manufactured

Some preparations are based mainly on calcium carbonate, silicate minerals, iron, or zinc. Their risk is usually driven by product purity, inappropriate indication, wrong dose, prolonged use, and patient susceptibility rather than by the inherent toxicity of lead or mercury.

• Shankha Bhasma: A conch-shell preparation, mainly calcium-rich, traditionally used for acid-peptic and digestive indications.
• Praval and Mukta preparations: Coral and pearl preparations are calcium-carbonate based but still require authenticity and contaminant checks.
• Abhraka Bhasma: A mica-based silicate preparation requiring careful processing and batch standardization.
• Lauha Bhasma: Iron-based; avoid unnecessary use in people with high ferritin, iron overload disorders, active infection concerns, or liver disease unless supervised.
• Yashada Bhasma: Zinc-based; avoid combining with other zinc supplements unless clinically indicated.

Moderate Concern Requiring Active Monitoring

These preparations can be clinically important in traditional practice, but the margin for error is smaller. Their use should be individualized, time-limited, and supported by batch-level testing.

• Tamra Bhasma: Copper-based; unsuitable for casual use, prolonged unsupervised courses, or patients with copper metabolism disorders.
• Vanga Bhasma: Tin-based; requires reliable manufacturing and practitioner supervision.
• Rajata Bhasma: Silver-based; chronic unnecessary exposure should be avoided.

High Concern and Specialist Use Only

Preparations containing lead, mercury, arsenic compounds, or closely related toxic mineral inputs require the highest safety threshold. They should never be treated as wellness supplements.

• Naga Bhasma: Lead-based; lead exposure is a genuine toxicological concern even when processed.
• Parada, Rasa Sindura, Makaradhwaja, and related mercury preparations: Require expert Rasa Shastra knowledge, legal compliance, contaminant testing, clear indication, limited duration, and monitoring.
• Formulations containing arsenic minerals: Require exceptional caution and should not be used without specialist oversight.

Quality Control Recommendations for Practitioners and Patients

The safest approach combines classical Rasa Shastra standards with modern laboratory quality control. Neither system should be used as a substitute for the other.

1. Use qualified supervision only: Bhasma preparations should be prescribed by a qualified Ayurvedic practitioner trained in Rasa Shastra, not self-selected from online listings.
2. Demand batch-level testing: A certificate of analysis should identify the batch and include elemental testing for lead, mercury, arsenic, cadmium, and relevant intended metals.
3. Prefer transparent manufacturers: The label should show batch number, manufacturing license details, ingredients, expiry, dose guidance, and safety warnings.
4. Verify identity and classical quality: Classical tests such as nishchandratva, rekhapurnatva, and varitaratva remain useful screening tools when performed by trained practitioners.
5. Avoid casual online purchase: Products sold without practitioner oversight, batch documentation, or transparent testing carry avoidable risk.
6. Use the lowest appropriate dose for the shortest appropriate duration: This principle is especially important for copper-, lead-, mercury-, arsenic-, and silver-containing preparations.
7. Use modern monitoring when risk is higher: Depending on the preparation, consider baseline and follow-up blood lead level, mercury level, liver function, kidney function, complete blood count, ferritin, copper status, or zinc status.
8. Disclose all medicines: Patients should tell both Ayurvedic and conventional healthcare providers about bhasma use, especially before surgery, pregnancy planning, or treatment for liver, kidney, neurological, gastrointestinal, or hematologic disease.

The Nanoparticle Dimension

Many bhasma discussions now use the word nanoparticle, but this needs precision. Some preparations contain nanoscale crystallites, some contain agglomerates of nanoparticles, and some measured batches show micrometre-scale particles. Particle size depends on raw material, grinding, calcination cycles, analytical method, and whether the measurement captures primary particles or agglomerates.

Nanoscale features may influence dissolution, surface area, tissue interaction, and dose behavior. They also add modern safety questions, because nanoscale materials can behave differently from bulk materials. For bhasma safety, particle-size claims should come from batch-specific SEM, TEM, XRD, DLS, or comparable analysis, not from the word bhasma alone.

A Balanced Safety Position

The most defensible position is neither to reject all bhasma as poison nor to accept all bhasma as safe. Properly prepared and properly prescribed bhasma is a distinct pharmaceutic category within Ayurveda. Poorly prepared, adulterated, mislabeled, or casually purchased products can cause real harm.

• Classical processing matters because incomplete incineration can leave unsuitable material.
• Modern batch testing matters because classical tests cannot quantify lead, mercury, arsenic, cadmium, or unintended contaminants.
• Chemical form matters because total elemental content does not equal absorbed toxic dose.
• Patient selection matters because children, pregnant or breastfeeding patients, and people with liver, kidney, neurological, or metabolic disorders may have much higher risk.
• Lead-, mercury-, and arsenic-containing preparations deserve the highest threshold of caution and should never be used as casual wellness supplements.

For a broader discussion of how carrier substances influence Ayurvedic administration, see The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Bhasma preparations should be used only under the supervision of a qualified Ayurvedic practitioner and, when appropriate, in coordination with a conventional healthcare provider. Do not self-medicate with mineral, metal, mercury, lead, arsenic, or herbo-mineral preparations. Seek medical care promptly if you develop abdominal pain, nausea, vomiting, constipation, metallic taste, fatigue, high blood pressure, tremor, neuropathy, confusion, anemia, kidney problems, or other symptoms suggestive of heavy-metal exposure. Children, pregnant or breastfeeding people, and patients with liver, kidney, neurological, or serious chronic illness should avoid bhasma unless a qualified specialist determines that use is appropriate and monitored.

References

1. Pdfs (pdfs.semanticscholar.org)
2. Pdfs (pdfs.semanticscholar.org)
3. Aamjournal (aamjournal.in)
4. Assessment of bioavailability of gold bhasma in human participants – A pilot study (2018), PubMed Central
5. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed
6. Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? (2008), PubMed Central
7. FDA
8. Ayush (ayush.delhi.gov.in)
9. Pib (pib.gov.in)
10. Scientific validation of the different purification steps involved in the preparation of an Indian Ayurvedic medicine, Lauha bhasma (2012), PubMed
11. Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central
12. Mail (mail.greenpharmacy.info)
13. Ijpsonline (ijpsonline.com)

Ayurvedic supplements are complex materials whose quality can change with botanical species, plant part, cultivation, harvest, drying, extraction, storage, and manufacturing. A label claim or a high percentage of one chemical constituent does not by itself establish that the product has the correct identity, is free from contamination, or resembles the material described in an official monograph. A sound quality assessment therefore combines botanical authentication, appropriate chemical testing, contaminant limits, manufacturing controls, traceability, and clear labeling.

The Standardization Problem in Botanical Supplements

Standardization usually means controlling one or more measurable constituents within a stated range. Marker compounds are useful for identification, batch consistency, or assay, but a marker is not necessarily the sole therapeutically relevant constituent. The World Health Organization states that identifying and quantifying marker substances alone is insufficient to guarantee the quality of a herbal medicine.

A botanical product can meet a marker specification while still having the wrong plant part, an unsuitable extraction process, an incomplete chemical fingerprint, excessive microbial contamination, pesticide residues, mycotoxins, or toxic-element contamination. Better specifications combine macroscopic or microscopic identity tests where applicable, chromatographic fingerprinting, validated assays, and risk-based contaminant testing. Quality must also be controlled from cultivation and collection through processing, packaging, and storage.

Ayurvedic Dravyaguna likewise evaluates a substance through more than a single laboratory number. Its framework includes dravya, rasa, guna, virya, vipaka, prabhava, and karma, while Ayurvedic pharmaceutics distinguishes powders, decoctions, medicated fats, fermented preparations, extracts, and other dosage forms. This traditional framework does not replace analytical quality control; it reinforces the need to identify the actual substance and preparation being supplied.

Quality Red Flags and Green Flags

Useful documentation should apply to the specific product and batch, not merely to the company or to a raw ingredient used in production. A certificate or verification seal should also be interpreted according to its stated testing scope.

Herb-Specific Quality Information

Official pharmacopoeial and formulary monographs establish identity and quality specifications for defined materials and preparations. They do not make all powders, extracts, and branded formulations interchangeable.

Ashwagandha (Withania somnifera): The Ayurvedic Pharmacopoeia of India lists Withania somnifera for Aśvagandhā and includes a separate monograph for Aśvagandhā powder. A supplement label should state the plant part and whether the contents are a powder or an extract. For an extract, the extraction solvent, extract ratio, and assay method are more informative than an unexplained “withanolides” percentage. The applicable specification should correspond to the particular material and preparation rather than a single percentage applied to every ashwagandha product.

Turmeric (Curcuma longa): The API identifies Haridrā powder as Curcuma longa. Whole turmeric powder, curcuminoid-rich extract, and enhanced-absorption curcumin products are different preparations. An extract should disclose its curcuminoid content and any added absorption enhancer. Greater absorption is not automatically safer; highly bioavailable curcumin formulations may harm the liver.

Brahmi (Bacopa monnieri): The API monograph identifies Brāhmī as Bacopa monnieri and also includes whole-plant and extract monographs. Because “brahmi” is used inconsistently in commerce and may also be applied to Centella asiatica, the botanical name is essential. Extract quantity, extraction method, marker specification, and assay method should be stated clearly because specifications differ among preparations.

Triphala: Triphalā Cūrṇa is an official Ayurvedic formulation. A transparent label should identify its three fruit ingredients: Harītakī (Terminalia chebula), Bibhītaka (Terminalia bellirica), and Āmalakī (Phyllanthus emblica, for which Emblica officinalis is a widely used synonym). The label should also state the ingredient proportions and whether the product is a powder or an extract.

Shilajit: Numerical fulvic-acid claims alone do not establish identity, purification, or safety. Prefer a clearly identified purified product with source and processing information, together with lot-specific testing for lead, mercury, arsenic, cadmium, and microbiological contamination. Raw or inadequately characterized material should not be treated as equivalent to a finished, quality-controlled preparation.

The Heavy-Metal and Contaminant Problem

Lead, mercury, and arsenic exposure from some Ayurvedic products is documented by public-health authorities. Metals may enter through environmental contamination, processing equipment, or intentional mineral ingredients in certain herbo-mineral preparations. Geographical origin and marketing descriptions cannot replace appropriate batch testing.

Testing should be selected according to the material and its risks. A useful toxic-element panel commonly includes lead, mercury, arsenic, and cadmium, with microbial limits, pesticide residues, and aflatoxins considered where relevant. Herbo-mineral products require especially careful ingredient disclosure, professional supervision, and compliance with applicable standards. A purely herbal product should not be assumed free from contamination merely because no mineral ingredient is declared.

Testing Resources for Consumers

Independent programs can add useful assurance, but each program has a defined purpose. Certification addresses only the criteria within its scope and does not establish that a supplement will treat a disease or be appropriate for a particular person.

Preparation and Bioavailability

Preparation form is part of product identity. A cūrṇa, kvātha, ghṛta, taila, āsava, ariṣṭa, and concentrated extract are not interchangeable merely because they contain the same named herb. Processing can change the constituents delivered, their concentration, stability, and absorption. Comparisons should therefore be made between clearly characterized preparations rather than between products joined only by a common ingredient name.

Liposomal, nanoparticle, phytosome, and piperine-containing products should disclose their composition and be assessed according to their own quality, dose, interaction, and safety information. They should not automatically be described as modern equivalents of medicated ghee, fermentation, or classical herbal combinations. Enhanced bioavailability can increase exposure as well as the possibility of adverse effects.

A Practical Buying Checklist

Before purchase, confirm the botanical name, plant part, dosage form, quantity per serving, batch number, expiry date, and manufacturer. For extracts, check the extract ratio, solvent, marker specification, and assay method. Ask for a lot-specific certificate showing actual results rather than a generic statement that the product “passes.” Verify third-party seals through the certifier and be cautious when ingredient quantities or preparation details are concealed.

Safety note: Natural origin does not guarantee safety, purity, or effectiveness. Ayurvedic supplements can cause adverse effects and interact with medicines. Children, people who are pregnant or breastfeeding, those with liver or kidney disease, those preparing for surgery, and anyone receiving treatment for a chronic condition require individualized advice. Ashwagandha should be avoided during pregnancy and breastfeeding and has rarely been linked to liver injury; highly bioavailable curcumin products also carry liver-safety concerns. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before starting a supplement, especially a concentrated extract or herbo-mineral preparation.

References

1. Cdn (cdn.who.int)
2. World Health Organization
3. World Health Organization
4. Ncismindia (ncismindia.org)
5. Ncismindia (ncismindia.org)
6. Ecfr (ecfr.gov)
7. Ayurvedic Pharmacopoeia of India
8. Ayurvedic Pharmacopoeia of India
9. NCCIH
10. Ayurvedic Pharmacopoeia of India
11. NCCIH
12. Ayurvedic Pharmacopoeia of India
13. Ayurvedic Pharmacopoeia of India
14. Ayurvedic Pharmacopoeia of India
15. Ayurvedic Pharmacopoeia of India
16. Powo (powo.science.kew.org)
17. FDA
18. FDA
19. Usp (usp.org)
20. Nsf (nsf.org)
21. Nsf (nsf.org)
22. Informed-sport (informed-sport.com)
23. FDA

A separate investigation involving users of Ayurvedic products in an Iowa community found that 46 of 115 participants had blood lead concentrations of at least 10 micrograms per decilitre. That value was the investigation’s case threshold, not the current CDC reference value. The CDC now uses 3.5 micrograms per decilitre to identify children with blood lead levels higher than most children’s levels, and it states that this reference value is not a toxicity threshold. No safe blood lead level has been identified for children.

The Two Pathways by Which Metals Enter Ayurvedic Products

Metals may enter an Ayurvedic medicine unintentionally as contaminants or may be deliberately included as named ingredients in a classical herbo-mineral formulation. These situations require different forms of assessment, but neither should be judged from packaging claims alone.

Unintentional Environmental or Manufacturing Contamination

Medicinal plants can acquire arsenic, cadmium, lead, mercury, and other elements from soil, irrigation water, atmospheric deposition, fertilisers, pesticides, storage containers, grinding equipment, or cross-contamination during manufacture. The World Health Organization’s quality-control manual identifies environmental pollution and agricultural practices as possible sources of arsenic and heavy metals in medicinal plant materials. Similar contamination can affect botanical products from any medical tradition.

A 2018 public-health investigation analysed 252 Ayurvedic samples obtained during the investigation of a lead-poisoning cluster. Lead was detected in 65% of those samples, mercury in 38%, and arsenic in 32%. Because the samples were collected in a cluster investigation rather than through random market sampling, those percentages should not be treated as prevalence estimates for all Ayurvedic medicines. They do demonstrate that contaminated and intentionally metal-containing products can occur together within a supply chain.

Intentional Inclusion in Rasa Shastra Formulations

Rasa shastra is the Ayurvedic pharmaceutical discipline in which specified herbs may be combined with processed metals, minerals, salts, or gems. Preparations known as bhasmas are produced through procedures that may include shodhana or preparatory processing, wet trituration with prescribed media known as bhavana, and controlled heating or calcination known as marana. The ingredients and processing sequence differ according to the substance and formula; there is no single cycle count, temperature schedule, or processing medium applicable to every bhasma.

Classical and contemporary formulations may include processed gold (Swarna or Suvarna Bhasma), silver (Rajata Bhasma), iron (Lauha Bhasma), copper (Tamra Bhasma), tin (Vanga Bhasma), lead (Naga Bhasma), mica (Abhraka Bhasma), mercury-containing ingredients such as Parada or Hingula, and arsenic-containing substances such as Hartala and Manahshila. These are not interchangeable with ordinary herbal powders and should not be used without appropriate professional supervision and dependable pharmaceutical quality control.

What Product Surveys Have Established

The 2008 internet-market study distinguished products marketed as rasa shastra medicines from products described as non-rasa-shastra medicines. Detectable lead, mercury, or arsenic occurred in 40.6% of the rasa-shastra products and 17.1% of the others. The rasa-shastra products were therefore about 2.4 times, rather than six times, as likely to contain one or more of the measured elements.

The presence of an element does not by itself establish its source, chemical form, absorption, or clinical effect. Nevertheless, total concentration and the labelled daily dose are essential safety measurements. A product that supplies an excessive daily quantity of lead, mercury, arsenic, or cadmium remains a concern regardless of whether the element entered through soil, manufacturing equipment, substitution, cross-contamination, or deliberate formulation.

Documented poisonings have been associated with Ayurvedic products containing excessive concentrations of toxic elements. Public-health agencies in the United States and Australia have continued to issue warnings about specific imported or unapproved products containing lead, mercury, arsenic, and, in some cases, other undeclared toxic substances. Consumers should act on a warning for the named product and batch rather than assuming that country of origin, price, a “natural” claim, or traditional terminology guarantees quality.

How Regulatory Frameworks Differ

Ayurvedic products may be regulated as medicines, traditional herbal medicines, dietary supplements, complementary medicines, or imported unapproved products, depending on the jurisdiction and the claims made for them. The practical question is not merely whether a country has a numerical metal limit, but which legal category applies to the specific product and what evidence was reviewed before sale.

Why a Single “Permissible ppm” Number Is Inadequate

Acceptable specifications depend on the product category, element, daily dose, route of administration, intended duration, applicable pharmacopoeia, and national law. Concentration expressed in parts per million or milligrams per kilogram must be considered together with the quantity consumed each day. Two products with the same concentration can produce different daily exposure when their recommended doses differ greatly.

The WHO manual on medicinal plant materials proposed maximum amounts of 10 milligrams per kilogram for lead and 0.3 milligrams per kilogram for cadmium in dried plant materials. It did not establish a universal four-element limit of 10 ppm lead, 1 ppm mercury, 3 ppm arsenic, and 0.3 ppm cadmium for every herbal medicine, dietary supplement, bhasma, and finished dosage form. A laboratory report should identify the specification used rather than merely stating “within WHO limits.”

Voluntary product-level programmes can provide additional assurance. The USP Verified programme evaluates identity, labelled strength or amount, contaminants such as heavy metals, manufacturing practices, and product performance. NSF/ANSI 173 certification likewise includes label-claim and contaminant requirements. These marks should be verified in the certifier’s current online directory because a facility-level GMP certificate is different from certification of a particular finished product.

Reading the Ingredient List for Metal and Mineral Components

Dosage form alone does not determine whether a product is herbal-only. A churna, vati, gutika, avaleha, asava, arishta, oil, capsule, or tablet may be herbal or may form part of a multi-ingredient preparation. The complete formula and source text or manufacturer’s specification must be examined.

Terms that warrant closer review include:

• Bhasma, indicating a specifically processed ash or calcined material.
• Parada, Hingula, Rasa Sindura, or related mercury-containing ingredients.
• Naga, Vanga, Tamra, Lauha, Mandura, Yashada, Rajata, or Swarna/Suvarna when used as processed metal ingredients.
• Hartala, Manahshila, or Gauripashana, which are arsenic-containing mineral substances.
• Abhraka, Makshika, and other mineral ingredients requiring substance-specific processing and testing.

A single-herb powder or extract labelled only with a verified botanical species, plant part, and excipients has no declared herbo-metallic ingredient, but it can still contain environmental or manufacturing contaminants. Conversely, familiar formula names should not be classified as safe or hazardous solely from the name because compositions can differ among classical references, proprietary versions, and manufacturers.

How Bhasma Preparation and Testing Should Be Understood

Traditional bhasma manufacture is substance-specific. Processes described in rasa-shastra literature may use repeated purification, grinding, levigation with designated liquids, pellet formation, sealing, and controlled heating. Classical finishing examinations such as nischandratva, rekhapurnatva, varitara, apunarbhava, and niruttha assess characteristics such as absence of metallic lustre, fineness, floating behaviour, and resistance to reversion under specified conditions. They form part of traditional pharmaceutical assessment but do not replace contemporary chemical, microbiological, and toxicological controls.

Instrumental methods answer different questions. Inductively coupled plasma mass spectrometry or optical-emission spectrometry can quantify total elemental content. X-ray diffraction can help identify crystalline phases, while electron microscopy can describe particle size and morphology. Additional methods may be needed to examine chemical speciation, dissolution, bioaccessibility, organic contaminants, microbes, pesticides, and batch-to-batch consistency. A result from one technique should not be presented as proof that a product is nontoxic.

One published characterization reported globular gold-containing particles averaging approximately 56–57 nanometres in a particular Swarna Bhasma sample. Other bhasma analyses have reported different particle sizes, aggregates, and chemical phases. The measurement therefore describes the tested material, not every Swarna Bhasma or all bhasmas. The presence of nanoscale particles is an analytical characteristic rather than an independent guarantee of purity, therapeutic benefit, or safety.

A Practical Consumer Safety Checklist

A responsible purchase should be traceable from the labelled ingredients and lot number to the manufacturer and the results for that production batch. The following checks are more useful than broad claims such as “ancient,” “natural,” “organic,” “laboratory tested,” or “made in an FDA-registered facility.”

1. Read every ingredient: Confirm the botanical name, plant part, extract ratio where relevant, excipients, and every metal or mineral ingredient. Do not rely only on the front-label product name.
2. Match the product to its regulatory category: Check the manufacturing licence and required particulars in India, a THR registration in the United Kingdom, an ARTG number in Australia, or applicable dietary-supplement labelling in the United States.
3. Request a batch-specific Certificate of Analysis: The report should match the lot number and identify the laboratory, test date, method, reporting units, detection or quantification limits, numerical results, and specifications for lead, cadmium, arsenic, and mercury.
4. Prefer an accredited laboratory: Look for testing performed within the laboratory’s accredited scope, commonly under ISO/IEC 17025. A manufacturer-created summary containing only the word “pass” provides less information than the signed analytical report.
5. Distinguish product certification from factory certification: GMP is important, but it does not mean that every finished batch has independently passed every contaminant test. Confirm whether a USP or NSF mark applies to the exact product.
6. Use greater caution with herbo-mineral products: Do not self-prescribe products containing lead-, mercury-, or arsenic-derived ingredients. Obtain them only under the guidance of a qualified Ayurvedic practitioner who can assess the indication, dose, duration, contraindications, and source.
7. Protect children and pregnancy: Children, fetuses, and pregnant people require particular protection from lead exposure. Discuss all Ayurvedic medicines and supplements with the treating healthcare professional before use.
8. Keep traceability records: Retain the container, invoice, batch number, expiry date, photographs of the label, and remaining tablets or powder if an adverse event or exposure concern arises.
9. Check regulator alerts: Search the relevant national regulator’s current safety notices before purchasing an imported product, especially when the seller provides no verifiable manufacturer or batch information.

Quality Control for Herbal-Only Products

Absence of an intentional metal ingredient is only one aspect of botanical quality. Correct identity requires the proper genus, species, plant part, and, where relevant, macroscopic, microscopic, chemical, or chromatographic characteristics. Substitution with a related species, use of the wrong plant part, excessive foreign matter, poor storage, and degradation can change a product even when its metal results are acceptable.

A suitable quality programme may also address pesticides, microbial contamination, aflatoxins or other mycotoxins, residual solvents, foreign matter, and adulterants according to the product and manufacturing process. Consumers should therefore avoid treating a heavy-metal certificate as a complete certificate of safety. It is one important component of identity, purity, strength, and contamination control.

Actionable Tip: Select one Ayurvedic product you currently use and compare its lot number with its Certificate of Analysis. Confirm that the document reports actual numerical results for lead, cadmium, arsenic, and mercury, names the analytical method and laboratory, and states the specification applied. When the manufacturer cannot provide a traceable batch report, the ingredients are incomplete, or the product contains a metal or mineral that was not clearly disclosed at purchase, pause further use and seek advice from a qualified practitioner or healthcare provider.

References

1. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed
2. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed Central
3. A cluster of lead poisoning among consumers of Ayurvedic medicine (2015), PubMed Central
4. CDC
5. CDC
6. World Health Organization
7. Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central
8. Bhasma : The ancient Indian nanomedicine (2014), PubMed Central
9. Characterization of Tarakeshwara Rasa: An Ayurvedic herbomineral formulation (2012), PubMed Central
10. FDA
11. FDA
12. CDSCO (India)
13. CDSCO (India)
14. Ema (ema.europa.eu)
15. Ema (ema.europa.eu)
16. Gov (gov.uk)
17. Assets (assets.publishing.service.gov.uk)
18. Tga (tga.gov.au)
19. Tga (tga.gov.au)
20. Usp (usp.org)
21. Nsf (nsf.org)
22. A critical appraisal on Swarnaprashana in children (2014), PubMed Central
23. World Health Organization
24. CDC